title: The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit.
abstract: OBJECTIVE
  To investigate the APO(*)E3-Leiden mouse as an animal model for age related maculopathy (ARM) related extracellular deposits.
  
  
  METHODS
  Eyes were obtained from APO(*)E3-Leiden transgenic mice on a high fat/cholesterol (HFC) diet (n=12) or on a normal mouse chow (n=6), for 9 months. As controls, eyes were collected from APO-E knockout mice on the same diets. From each mouse one eye was processed for microscopic evaluation and immunohistochemistry with a polyclonal antibody directed against human apo-E. Electron microscopy was also performed.
  
  
  RESULTS
  All 12 eyes of the APO(*)E3-Leiden mice on an HFC diet contained basal laminar deposit (BLD; class 1 to class 3), whereas two of six APO(*)E3-Leiden mice on normal chow showed BLD class 1. The ultrastructural aspects of this BLD were comparable with those seen in early BLD in humans, and BLD showed immunoreaction with anti-human-apo-E antibodies. No BLD was found in any of the control mice. Drusen were not detected in any of the mice.
  
  
  CONCLUSIONS
  These results indicate that APO(*)E3-Leiden mice can be used as animal model for the pathogenesis of BLD, and that a HFC diet enhances the accumulation of this deposit. Furthermore, this study supports the previously suggested involvement of dysfunctional apo-E in the accumulation of extracellular deposits in ARM.
authors.affiliation: Department of Pathology, Erasmus University, Rotterdam, Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Kliffen
authors.forename: E
authors.initials: E
authors.lastname: Lutgens
authors.forename: M J
authors.initials: MJ
authors.lastname: Daemen
authors.forename: E D
authors.initials: ED
authors.lastname: de Muinck
authors.forename: C M
authors.initials: CM
authors.lastname: Mooy
authors.forename: P T
authors.initials: PT
authors.lastname: de Jong
mesh_terms: D000818:Animals; D053318:Apolipoprotein E3; D001057:Apolipoproteins E / Q000235:genetics* / Q000378:metabolism; D001485:Basement Membrane / Q000648:ultrastructure; D004041:Dietary Fats / Q000008:administration & dosage; D004195:Disease Models, Animal; D006801:Humans; D007124:Immunoenzyme Techniques; D008268:Macular Degeneration / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics*; D012160:Retina / Q000378:metabolism / Q000648:ultrastructure
chemical_list: D053318:Apolipoprotein E3; D001057:Apolipoproteins E; D004041:Dietary Fats